# Cablivi

NDC: 58468-0225
Generic name: caplacizumab
Labeler / Manufacturer: Genzyme Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20190206

FDA application: BLA761112

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58468-0225"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58468-0225
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2348f06e-8004-4040-832e-e9e86a39f905